NewcelX Ltd. Ordinary Shares (NCEL)

• Market cap: $15.4M
• 1 day: -28.81%
• 5 days: -56.75%
• 1 month: -74.05%
• 3 months: -72.54%
• 6 months: -69.65%
• Year to date: -76.19%
• 1 year: -88.18%
• 5 years: -99.55%
• 10 years: -99.55%
• Sector: Healthcare
• Industry: Biotechnology

About: Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Employees: 11